The system never gets a meaningful break from stimulation
This dose-response relationship across receptor activation suggests that the more pathways you stimulate, the higher the likelihood of neurological side effects including skin sensitivity
The plan to run more than 20 pivotal studies, including multiple Phase 3 trials, signals that obesity is intended to be a large, multi-year revenue stream that can help offset pressure from lower COVID-19 product sales and upcoming patent losses
[35] On top of that, labels may not match whats actually inside, and since supplement patches dont require the same oversight as prescriptions, theres no way to be sure the dose, purity, or even the listed ingredients are accurate
It can be difficult for consumers to tell the difference or trust the quality of the obesity drugs they're buying
Complex peptides like retatrutide have real manufacturing costs that cannot be circumvented without sacrificing quality